Stephen A. Hill, Director at Cellectar Biosciences, Inc. (CLRB), sold 992 shares at $2.21 ($2K) on 2018-11-29, disclosed to the SEC on 2018-11-30.
Open-market sale of $2k CLRB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.21 | 53 | $117 | 5.3% |
| 2 | $2.21 | 939 | $2K | 94.7% |
| Total | $2.21 avg | 992 | $2K | 100% |
| Filing → |
| CLRB | BUY | 2016-04-21 | $20K | — | Filing → |
| CBIO | BUY | 2015-12-18 | $10K | — | Filing → |
| LPCN | BUY | 2014-11-13 | $20K | — | Filing → |